PTE - PolarityTE

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• PolarityTE GAAP EPS of -$0.47
• Biotech firm Polarityte surges as it confirms receipt of $1.25/share acquisition bid
• PolarityTE down 10% on lower-than-expected Q2 revenue
• PolarityTE GAAP EPS of -$0.49 beats by $0.13, revenue of $0.07M misses by $0.43M
• PolarityTE Q2 2022 Earnings Preview
• ACADIA Pharmaceuticals, GeoPark, Gran Tierra Energy among premarket losers' pack
• PolarityTE files secondary offering for up to 4.75M shares
• PolarityTE to raise $8M in registered direct and private placement offerings
• PolarityTE stock slides on 1-for-25 reverse stock split
• PolarityTE stock falls 13% on Q1 profit miss
• PolarityTE Non-GAAP EPS of -$0.10 misses by $0.02, revenue of $0.74M beats by $0.01M
• PolarityTE Q1 2022 Earnings Preview
• PolarityTE stock soars 70% on FDA regenerative medicine status to SkinTE
• PolarityTE GAAP EPS of -$0.38 misses by $0.06, revenue of $9.4M beats by $1.32M
• PolarityTE slumps on ~$5M securities offering
• PolarityTE stock rises 4% on getting US patent
• PolarityTE gets US FDA clearance to begin phase 3 trial of SkinTE for chronic ulcers
• PolarityTE submits complete response to FDA's clinical hold for SkinTE application
• PolarityTE EPS beats by $0.03, beats on revenue
• PolarityTE Q3 2021 Earnings Preview